Hangzhou innogate pharma

Author: jvdg

August undefined, 2024

WebOct 31, 2024 · Hangzhou Innogate Pharma Co. Ltd. has synthesized GTPase KRAS (Gly12Asp mutant) inhibitors reported to be useful for the treatment of cancer. … WebHANGZHOU INNOGATE PHARMA CO LTD has a total of 39 patent applications. It decreased the IP activity by 77.0%. Its first patent ever was published in 2016. It filed its patents most often in China, WIPO (World Intellectual Property Organization) and …

Hangzhou Innogate Pharma synthesizes new KAT6A inhibitors

WebOther pharma companies with tricyclic IDO1 inhibitors in their pipeline at present are Hangzhou Innogate Pharma Co., Ltd. [88], Shanghai De Novo Pharmatech Co., Ltd. [89,90] and Redx Pharma plc [91,92]. In summary, the modification mainly focus on the replacements of the benzene motif by 5- or 6- membered heteroaryl groups to fill pocket … WebFeb 15, 2024 · Hangzhou Innogate Pharma Co. Ltd. has identified kinesin-like protein KIF18A inhibitors reported to be useful for the treatment of cancer and viral infections. All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. gage assault weapon pack

HETEROCYCLIC COMPOUND SERVING AS FGFR4 INHIBITOR - Hangzhou Innogate …

Web专利顾如平台提供关于 protein kinase inhibitors 的专利信息查询，本次查询共找到了37545条关于 protein kinase inhibitors 的专利信息，专利顾如是创新者都在用的专利研发平台,专利检索,专利深度分析跟踪平台 WebHangzhou Innogate Pharma Co., Ltd. US Patent. Ligand BDBM408633 (US10358451, Compound 18k-2) Show SMILES. Show InChI. Affinity Data IC50: 100nM Assay … WebHangzhou Innogate Pharma Co., Ltd. US Patent: Assay Description In vitro TDO enzymatic activity was determined in a mixture of 50 mM potassium phosphate buffer, pH 6.5; 200 nM human TDO enzyme, 300 μM L-Trypt... US Patent US10358451 (2024) BindingDB Entry DOI: 10.7270/Q26112P0: More data for this Ligand-Target Pair: … black and white nike nsw block t shirt

POLYCYCLIC COMPOUND ACTING AS KINASE INHIBITOR - HANGZHOU INNOGATE …

WebSep 8, 2024 · Hangzhou Innogate Pharma Co. Ltd. has divulged new NLRP3 inflammasome inhibitors reported to be useful for the treatment of inflammation, cancer, infections and metabolic, respiratory, liver, kidney and autoimmune diseases, among other disorders. BioWorld Science Inflammatory Patents WebMay 27, 2024 · A heterocyclic compound which is an inhibitor of FGFR4 (fibroblast growth factor receptor 4) is described. Specifically, a compound represented by the following formula (I), including an isomer (enantiomer or diastereomer) which may be present, or a pharmaceutically acceptable salt thereof, prodrugs, deuterated derivatives, hydrates, … gage a reactionWebHangzhou Innogate Pharma Company, Ltd. Locations. Hangzhou Innogate Pharma Company, Ltd. Locations. Go back to Hangzhou Innogate Pharma Company, Ltd. 's … black and white nike lows

"WebHangzhou Innogate Pharma Co., Ltd. US Patent. Ligand BDBM408630 (4-(2-(6-fluoro-5H-imidazo[5,1-a]isoindol-5-yl)-1-h...) Show SMILES. Show InChI. Affinity Data IC50: 100nM Assay Description: In vitro IDO1 enzymatic activity was determined in a mixture of 50 mM MES buffer at pH 6.5; 200 nM human IDO enzyme, 150 μM L ... " - Hangzhou innogate pharma

Hangzhou innogate pharma

WebHangzhou Innogate Pharma Co Ltd Original Assignee Hangzhou Innogate Pharma Co Ltd Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) 2015-04-12 Filing date 2016-04-12 Publication date 2024-10-24 WebHANGZHOU INNOGATE PHARMA CO LTD has a total of 39 patent applications. It decreased the IP activity by 77.0%. Its first patent ever was published in 2016. It filed its …

Did you know?

WebIt filed its patents most often in China, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are HANGZHOU INNOGATE PHARMA CO LTD, MNEMOSYNE PHARMACEUTICALS INC and DAJITI FARMAS JUTIKAL KO LTD. Map … WebJan 31, 2024 · Hangzhou Innogate Pharma synthesizes new KAT6A inhibitors Jan. 31, 2024 Hangzhou Innogate Pharma Co. Ltd. has discovered histone acetyltransferase KAT6A inhibitors reported to be useful for the treatment …

WebHangzhou Innogate Pharma Company, Ltd. China International Organization No tags have been applied so far. Sign in to add some. Profile People (0) Documents (0) Dockets (0) … WebJun 7, 2024 · Assigned to Hangzhou Innogate Pharma Co., Ltd., Zhejiang (CN) Filed by Hangzhou Innogate Pharma Co., Ltd., Zhejiang (CN) PCT Filed May 27, 2024, PCT …

WebHangzhou Normal University: Hangzhou, Zhejiang, CN . 2024-12-01 to present Professor ... Source: Xiang-Yang Ye Hangzhou Innogate Pharma Co. Ltd.: Hangzhou, Zhejiang, CN . 2024-01-01 to present. Employment Show more detail. Source: Xiang-Yang Ye Bristol-Myers Squibb: Princeton, NJ, US . 2002-09-01 to 2016 ... WebHangzhou Innogate Pharma Company, Ltd. China International Organization No tags have been applied so far. Sign in to add some. Profile People (0) Documents (0) Dockets (0) Attorneys (2) Markets (0) Patents (14) Trademarks (0) Payments (0) Related (0)

WebDec 13, 2016 - Hangzhou Innogate Pharma Co., Ltd. The present invention provides compounds of Formula (I), and the pharmaceutically acceptable salts, hydrates, and …

WebInnogate Pharma Co., Ltd. May 2024 - Present4 years 11 months Hangzhou, Zhejiang, China Chief Scientific Officer Global Health Drug Discovery Institute Sep 2024 - May … black and white nike leggingsWebPOLYCYCLIC COMPOUND ACTING AS KINASE INHIBITOR - HANGZHOU INNOGATE PHARMA CO., LTD. Title: POLYCYCLIC COMPOUND ACTING AS KINASE INHIBITOR Document Type and Number: United States Patent Application 20240095043 Kind Code: A1 Abstract: The present invention provides a class of compounds containing tricyclic … black and white nike jordan shoesWeb2 articles for Hangzhou Innogate Pharma Co., Ltd. The following articles (labelled with PubMed ID or TBD) are for your review; PMID Article Title Published Deposition; … gage associationWebJan 18, 2024 · Hangzhou Innogate Pharma describes new KIF18A inhibitors Jan. 18, 2024 Hangzhou Innogate Pharma Co. Ltd. has identified kinesin-like protein KIF18A … gage are you the oneWebGo back to Hangzhou Innogate Pharma Company, Ltd.'s page. 1: South, 18/f, Building 4, 1500 West Wenyi Road Cangqian Town, Yuhang District Hangzhou, Zhejiang 311121 CHINA Get Directions: 2: 18/f, Building 4, 1500 West Wenyi Road Sci-tech Incubation Center, Yuhang District Hangzhou Zhejiang 311121 black and white nike low topsWebNov 7, 2024 · Hangzhou Innogate Pharma Co Ltd Original Assignee Hangzhou Innogate Pharma Co Ltd Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) 2016-12-12 Filing date 2024-12-12 Publication date … gage art seattleWeb( 73 ) Assignee : Hangzhou Innogate Pharma Co. , Ltd. , Zhejiang ( CN ) CN CN CN WO 1433417 A 101001857 A 105294736 A ... black and white nike shirt